Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
-
Published:2021-06
Issue:
Volume:150
Page:108-118
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Duffaud Florence, Italiano Antoine, Bompas Emannuelle, Rios Maria, Penel Nicolas, Mir OlivierORCID, Piperno-Neumann Sophie, Chevreau Christine, Delcambre Corinne, Bertucci François, Boudou-Rouquette Pascaline, Cancel MathildeORCID, Perrin Christophe, Saada-Bouzid Esma, Monard LaureORCID, Schiffler Camille, Chaigneau Loic, Hervieu Alice, Collard Olivier, Bouvier Corinne, Vidal Vincent, Chabaud Sylvie, Blay Jean-YvesORCID
Subject
Cancer Research,Oncology
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real‐world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study;Cancer Medicine;2023-09 2. Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma;Clinical Cancer Research;2023-06-02 3. Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study;ESMO Open;2023-06 4. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas;American Society of Clinical Oncology Educational Book;2023-05 5. Ewing sarcoma genomics and recent therapeutic advancements;Pediatric Hematology Oncology Journal;2023-03
|
|